Comparative analysis between control actions and cervical cancer mortality in Pará between 2016 and 2021
DOI:
https://doi.org/10.33448/rsd-v12i13.44241Keywords:
Epidemiology; Uterine cervical neoplasms; Mortality; Papanicolaou test.Abstract
Introduction: Cervical cancer has an aggressive global incidence and high mortality in countries with insufficient control and prevention strategies. Objective: to analyze the relationship between mortality rates from cervical cancer (CC) and control strategies for this disease, in the state of Pará. Methods: This is an ecological, descriptive and time series study, using data registered in SIA/DATASUS, SISCAN and SIH/DATASUS, with data collection on primary variables being carried out from 2016 to 2021. Results: In the period analyzed, a downward trend in cytopathological exams carried out in Pará was identified, being opposite to high mortality rate from cervical cancer. More exams were carried out in the age range between 20 and 39 years old, in addition to the Lower Amazon region having the biggest decline among health regions in the same period. The variation in the mortality rate remained heterogeneous between regions, with the Baixo Amazonas and the Tocantins region showing the most significant increases. Conclusion: Mortality associated with CC, in Pará, was mainly associated with the black race and the population of elderly women, whose prevalence increased from the age of 60, in addition to the fact that the performance of oncotic Pap smear tests showed a progressive decline. between the years analyzed, indicating an association with the variation in the mortality rate.
References
Almeida, A. C. & Oliveira, K. B. (2014). Câncer de Colo Uterino: desenvolvimento, diagnóstico, tratamento e marcadores moleculares. Saud Pesq., 7(1): 155-161.
Alves, N. B., Júnior, J. F. S., & Oliveira, E. H. (2022). Mortalidade por neoplasia maligna do colo do útero no estado do Ceará de 2014 a 2019: perfil epidemiológico. Res, Soc Dev., 11(5): 1-11.
IBGE. (2012). Censo Demográfico 2010: Características da População e dos Domicílios. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística (IBGE). https://www.ibge.gov.br/estatisticas/sociais/populacao/9662-censo-demografico-2010.html?edicao=10503&t=resultados.
Claro, I. B., Lima, L. D., & Almeida, P. F. (2021). Cervical cancer guidelines, prevention and screening strategies: experiences from Brazil and Chile. Cien Saude Colet., 26(10): 4497-4509.
Cohen, P. A., et al. (2019). Cervical cancer. Lancet, 393 (10167): 169-182.
Colpani, V., et al. (2020). Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One., 15(2): 1-34.
Corrêa, F. M., et al. (2022). Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination. Front Med., 24: 1-10.
Gasparin, V. A., et al. (2020). Rastreamento do câncer de colo do útero durante o acompanhamento pré-natal. Rev Eletr Enf, 22:1-8.
Guerra, M. R., et al. (2017). Magnitude and variation of the burden of cancer mortality in Brazil and Federation Units, 1990 and 2015. Rev Bras Epidemiol., 20(1): 102-117.
Johnson, C. A., et al. (2019). Cervical cancer: an overview of pathophysiology and management. Semin Oncol, 35(2):166-174.
Landy, R., et al. (2016). Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study. Br J Cancer., 115(9): 1140-1146.
Lei, J., et al. (2020). HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med., 383(14):1340-1348.
Merchán-Haman, E. & Tauil, P. L. (2021). Proposta de classificação dos diferentes tipos de estudos epidemiológicos descritivos. Epidemiol. Serv. Saúde. 30 (1): 1-13.
Monteiro, J. C., et al. (2022). Prevalence, Diversity, and Risk Factors for Cervical HPV Infection in Women Screened for Cervical Cancer in Belém, Pará, Northern Brazil. Pathogens., 11(9): 1-11.
Paulino, E., et al. (2020). Panorama of gynecologic cancer in Brazil. JCO Glob., 6: 1617-1630.
Pilleron, S., et al. (2020). Cervical cancer burden in Latin America and the Caribbean: Where are we?. Int J Cancer, 147(6): 1638-1648.
Primo, W. Q. S. P., et al. (2021). Call to eliminate cervical cancer in the next decade with a focus on Brazil. Rev Bras Ginecol Obstet, 43(1):1-2.
Ribeiro, A., et al. (2021). Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies. Cancer Prev Res.,14(10):919-926.
Ribeiro, C. M., et al. (2019). Parâmetros para a programação de procedimentos da linha de cuidado do câncer do colo do útero no Brasil. Cad Saúde Pública, 35(6): 1-13.
Rocha, T. A. H., et al. (2017). Primary health care and cervical cancer mortality rates in Brazil: a longitudinal ecological study. J Ambul Care Manag., 40(2): 24-34.
Sá, K. C. C. & Silva, L. R. (2019). O exame papanicolaou na prevenção do câncer no colo uterino: uma revisão integrativa. Revista Eletrônica da Faculdade Evangélica de Ceres, 8(1): 1-23.
Silva, G. A., et al. (2022). Avaliação das ações de controle do câncer de colo do útero no Brasil e regiões a partir dos dados registrados no Sistema Único de Saúde. Cad Saúde Pública., 38(7): 1-15.
Silva, G. A., et al. (2022). Evaluation of cervical cancer control actions within Brazil and its regions based on data recorded in the Brazilian Unified National Health System. Cad Saúde Pública, 38(7): 1-15.
Tallon, B., et al. (2020). Tendências da mortalidade por câncer de colo no Brasil em 5 anos (2012-2016). Saúde Debate, 44(125): 362-371.
Tsuchiya, C. T., et al. (2017). O câncer de colo do útero no Brasil: uma retrospectiva sobre as políticas públicas voltadas à saúde da mulher. J Bras Econ Saúde., 9(1): 137-147.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Alexandre Marques da Rocha; Ricardo Ormanes Massoud; Ádria Rayane Lima Cascaes; Mateus Itiro Tamazawskas Otake
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
